Identification | More | [Name]
3-Benzyloxybenzaldehyde | [CAS]
1700-37-4 | [Synonyms]
3-BENZYLOXYBENZALDEHYDE AKOS BBS-00003155 ASISCHEM N42207 M-BENZYLOXYBENZALDEHYDE Benzaldehyde, 3-(phenylmethoxy)- Benzaldehyde, m-(benzyloxy)- 3-Benzyloxybenzaldehyde98% 3-Benzyloxybenzaldehyde 98% 3-(Phenylmethoxy)benzaldehyde | [EINECS(EC#)]
216-932-8 | [Molecular Formula]
C14H12O2 | [MDL Number]
MFCD00003367 | [Molecular Weight]
212.24 | [MOL File]
1700-37-4.mol |
Chemical Properties | Back Directory | [Appearance]
WHITE TO LIGHT BEIGE FINE CRYSTALLINE POWDER | [Melting point ]
56-58 °C(lit.) | [Boiling point ]
180°C 0,08mm | [density ]
1.1035 (rough estimate) | [refractive index ]
1.6000 (estimate) | [Fp ]
180°C/0.08mm | [storage temp. ]
Keep in dark place,Sealed in dry,Room Temperature | [form ]
Fine Crystalline Powder | [color ]
White to light beige | [Water Solubility ]
Soluble in water 38.87 mg/L @ 25°C. | [Sensitive ]
Air Sensitive | [BRN ]
1956589 | [LogP]
2.960 (est) | [CAS DataBase Reference]
1700-37-4(CAS DataBase Reference) | [NIST Chemistry Reference]
Benzyl 3-formylphenyl ether(1700-37-4) |
Safety Data | Back Directory | [Hazard Codes ]
Xn | [Risk Statements ]
R20/21/22:Harmful by inhalation, in contact with skin and if swallowed . R36/37/38:Irritating to eyes, respiratory system and skin . | [Safety Statements ]
S24/25:Avoid contact with skin and eyes . S36:Wear suitable protective clothing . S26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice . | [WGK Germany ]
3
| [HazardClass ]
IRRITANT | [HS Code ]
29124990 |
Hazard Information | Back Directory | [Chemical Properties]
WHITE TO LIGHT BEIGE FINE CRYSTALLINE POWDER | [Uses]
3-Benzyloxybenzaldehyde is used as a pharmaceutical intermediate. It activates the adenyl cyclase. | [Synthesis]
The general procedure for the synthesis of 3-(benzyloxy)benzaldehyde from benzyl bromide and m-hydroxybenzaldehyde was as follows: m-hydroxybenzaldehyde (3 g, 24.6 mmol) and anhydrous potassium carbonate (10.2 g, 73.8 mmol) were suspended in N,N-dimethylformamide (60 mL). Benzyl bromide (3.21 mL, 27.1 mmol) was added dropwise to this suspension and the reaction was stirred at room temperature for 14 hours. Upon completion of the reaction, the reaction mixture was poured into a mixture of ethyl acetate and water for liquid-liquid partitioning. The organic phase was separated, washed three times with water, the organic phase was dried with anhydrous magnesium sulfate, and the desiccant was removed by filtration. The filtrate was concentrated under reduced pressure and the resulting crude product was purified by silica gel column chromatography with an eluent ratio of heptane:ethyl acetate (4:1 to 1:1 gradient elution) to afford the target compound 3-(benzyloxy)benzaldehyde (5.16 g, 99% yield). The product was characterized by 1H-NMR (CDCl3) with the following chemical shift δ (ppm): 5.13 (2H, s, -OCH2-), 7.24-7.25 (1H, m, aryl ring H), 7.35-7.49 (8H, m, aryl ring H), 9.98 (1H, s, -CHO). | [References]
[1] Journal of the American Chemical Society, 1994, vol. 116, # 18, p. 8402 - 8403 [2] Journal of Medicinal Chemistry, 2015, vol. 58, # 7, p. 3188 - 3208 [3] Patent: US2007/105904, 2007, A1. Location in patent: Page/Page column 112 [4] Molecules, 2010, vol. 15, # 11, p. 7971 - 7984 [5] Journal of the American Chemical Society, 2001, vol. 123, # 22, p. 5382 - 5383 |
|
|